NERI nabs $18M NIH contract for pediatric circulatory support devices

Thursday, June 28, 2012 02:37 PM

New England Research Institutes (NERI), a privately held CRO that provides global, customized clinical trial solutions and registry services, has received an $18 million contract from the National Institutes of Health (NIH) for the PumpKIN Program for the development and clinical realization of novel pediatric circulatory support devices, such as ventricular assist devices (VADs) and extracorporeal membrane oxygenation devices (ECMOs).

The endeavor will be lead by Lynn Sleeper, ScD, and Sharon Tennstedt, PhD, and the contract signifies $105 million in total funding for pediatric clinical trials services at NERI.

Approximately 70% of medications prescribed to children have only been tested in adults. While there are FDA initiatives, such as Pediatric Research Equity Act (PREA) and Best Pharmaceuticals for Children Act (BPCA), aimed to close the gap, NERI has been working to address this imbalance for two decades, and is in the forefront of pediatric research.

NERI provides clinical trial and registry services for pediatric indications using drug or device interventions, with record growth. Approximately one-half of all NERI clinical trials include pediatric subjects encompassing over 22,000 subjects across 490 U.S. and international research sites. NERI also develops tools to educate and inform parents, clinicians, researchers and children about clinical research. In collaboration with National Heart, Lung, and Blood Institute (NHLBI), NERI developed a website, documentary film, social media presence and tools for clinics on children and clinical studies.  

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 2

Roche's $8.3B InterMune buy continues its buying spree with 'bolt-on' deal, fueling record M&A activity

FDA action plan seeks to close gap in women and minority patient representation in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs